Jul 31 |
United Therapeutics (UTHR) Misses Q2 Earnings Estimates
|
Jul 31 |
United Therapeutics: Q2 Earnings Snapshot
|
Jul 31 |
United Therapeutics GAAP EPS of $5.85 misses by $0.55, revenue of $714.9M beats by $24.05M
|
Jul 31 |
United Therapeutics Corporation Reports Second Quarter 2024 Financial Results
|
Jul 30 |
United Therapeutics Q2 2024 Earnings Preview
|
Jul 30 |
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
|
Jul 26 |
Implied Volatility Surging for United Therapeutics (UTHR) Stock Options
|
Jul 26 |
The 3 Best 3D Bioprinting Stocks to Buy Now
|
Jul 25 |
Will PTC Therapeutics (PTCT) Report Negative Q2 Earnings? What You Should Know
|
Jul 24 |
United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024
|